Sort
21,281 grants matching “influenza”
Development of the Next Generation of Conjugate Vaccines
$894,543Luc Teyton · Scripps Research Institute, The · R01 · FY2018 · AI
Increasing the size of the specific pathogen free Indian rhesus macaques colony at the Southwest National Primate Research Center for AIDS, COVID-19 and other infectious diseases research
$894,342Larry S. Schlesinger · Texas Biomedical Research Institute · P51 · FY2021 · OD
Multi-component INTERLUNG intervention to protect lung health in Nepal
$893,525William N Checkley · Johns Hopkins University · R01 · FY2025 · ES
Containing Bioterrorist and Emerging Infectious Diseases
$893,467M Elizabeth Halloran · Fred Hutchinson Cancer Research Center · U01 · FY2011 · GM
Advanced Development of Vaccines for Infectious Diseases
$892,996Ly Phan · Versatope Therapeutics, Inc. · N01 · FY2022 · AI
Development of novel immunotherapy for influenza virus infection
$892,349Kazue Takahashi · Massachusetts General Hospital · U01 · FY2008 · AI
A Novel Live Non-replicating Universal Vaccine for Influenza
$892,212Sally R. Sarawar · Biomedical Research Instit/ Southern, Ca · R01 · FY2017 · AI
Development of RespiraClear for targeted mucosal treatment of RSV infections
$891,585Richard A Cone · Mucommune, Llc · R44 · FY2022 · AI
Novel mechanisms regulating immunity to respiratory virus infection
$890,660Silke Paust · Jackson Laboratory · R01 · FY2024 · AI
EVASION OF HOST IMMUNE RESPONSE BY INFLUENZA VIRUS
$889,201Mount Sinai School Of Medicine Of Nyu · P01 · FY2001 · AI
DNA Vaccine for Induction of Mucosal Immunity
$889,109David B. Weiner · University Of Pennsylvania · P01 · FY2011 · AI
Diagnostic and Prognostic Biomarkers for Viral Severe Lung Disease
$889,074Ralph S Baric · Columbia University Health Sciences · U19 · FY2018 · AI
Diagnostic and Prognostic Biomarkers for Viral Severe Lung Disease
$889,034Ralph S Baric · Columbia University Health Sciences · U19 · FY2016 · AI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)
$888,792Richard Webby · St. Jude Children'S Research Hospital · N01 · FY2018 · AI
Active Disposable Cap for Endoscope Tip Stabilization and Complete Visualization and Dissection of Serrated Sessile Polyps
$888,600Maureen L. Mulvihill · Actuated Medical, Inc. · R44 · FY2019 · DK
Project 4 - Influenza - UAB
$888,530Richard J. Whitley · University Of Alabama At Birmingham · U19 · FY2021 · AI
A Rapid Pan-Viral Microarray Diagnostic for Category A-C Biodefense Pathogens
$888,279Charles Yen Chiu · University Of California, San Francisco · R56 · FY2010 · AI
Recombinant Adenovirus Vector Vaccine Studies
$887,840Gary J Nabel · Niaid Extramural Activities · Z01 · FY2007 · AI
Clinical Trials of Vaccines for Respiratory Syncytial Virus and Related Viruses
$887,620Ursula Buchholz · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
A Universal Flu Vaccine Based On Conformationally Locked Soluble Headless HA
$887,615Mark Yondola · Calder Biosciences, Inc. · R44 · FY2020 · AG
Inflammation
$886,728Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Human Immunology Center at the University of Rochester
$886,541Tim Mosmann · University Of Rochester · R24 · FY2009 · AI
Development of Broad Spectrum Host Oriented Therapeutic Antibodies against Influe
$885,403Wu-Bo Li · Functional Genetics, Inc. · R44 · FY2010 · AI
The generation and protective function of lung tissue resident memory T cells following SARS-CoV-2 infection or vaccination
$884,886John Ross Teijaro · Scripps Research Institute, The · R01 · FY2024 · AI
Viral respiratory infections in a tracheostomy cohort: Microbiome-host interplay
$884,790Jonathan M Mansbach · Boston Children'S Hospital · R01 · FY2024 · AI